Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Blue light is not itself a molecular target but refers to electromagnetic radiation within the 400–500 nm wavelength range. Biological systems detect this environmental cue through specialized proteins called *blue-light photoreceptors*. These include several distinct families—cryptochromes (CRY), phototropins (PHOT), LOV-domain proteins, and BLUF-domain proteins—all characterized by their ability to absorb blue photons via flavin-based chromophores such as FAD or FMN. Upon activation by blue light, these receptors undergo structural changes that trigger downstream signaling events regulating diverse processes including plant growth orientation toward sunlight (*phototropism*), chloroplast movement, stomatal opening/closure in guard cells,[1] deetiolation,[3] root elongation,[6] flowering time control,[3] DNA repair mechanisms,[3] and entrainment of circadian rhythms both in plants and mammals.[7] While they are essential components across kingdoms from bacteria through plants to animals—including humans—they are not currently direct drug targets outside optogenetic applications used experimentally.[4]
Upon absorption of blue light by their flavin chromophores:\n– Undergo conformational changes that initiate signal transduction cascades via protein-protein interactions or regulation of gene expression pathways[4].\n– In plants, regulate transcription factors controlling growth responses.\n– In animals/mammals, entrain circadian clocks through neural signaling pathways involving cryptochromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blue-light photoreceptor (None universally established; specific families have abbreviations (e.g., CRY for cryptochrome, PHOT for phototropin, BLUF for blue light using FAD domain).).